Patents by Inventor Bernard Cuenoud

Bernard Cuenoud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Beta2-adrenoreceptor agonists
    Patent number: 8796307
    Abstract: Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
    Type: Grant
    Filed: November 11, 2013
    Date of Patent: August 5, 2014
    Assignee: Novartis AG
    Inventors: Bernard Cuenoud, Ian Bruce, Robin Alec Fairhurst, David Beattie
  • Beta2-Adrenoreceptor Agonists
    Publication number: 20140066478
    Abstract: Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways disease.
    Type: Application
    Filed: November 11, 2013
    Publication date: March 6, 2014
    Applicant: Novartis AG
    Inventors: Bernard Cuenoud, Ian Bruce, Robin Alec Fairhurst, David Beattie
  • BETA2-adrenoreceptor agonists
    Patent number: 8658673
    Abstract: Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
    Type: Grant
    Filed: April 8, 2013
    Date of Patent: February 25, 2014
    Assignee: Novartis AG
    Inventors: Bernard Cuenoud, Ian Bruce, Robin Alec Fairhurst, David Beattie
  • BETA2-ADRENORECEPTOR AGONISTS
    Publication number: 20130231367
    Abstract: Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
    Type: Application
    Filed: April 8, 2013
    Publication date: September 5, 2013
    Applicant: Novartis AG
    Inventors: Bernard Cuenoud, Ian Bruce, Robin Alec Fairhurst, David Beattie
  • Beta-2-adrenoreceptor agonists
    Patent number: 8436017
    Abstract: Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
    Type: Grant
    Filed: July 23, 2012
    Date of Patent: May 7, 2013
    Assignee: Novartis AG
    Inventors: Bernard Cuenoud, Ian Bruce, Robin Alec Fairhurst, David Beattie
  • Inhibitors of phosphatidylinositol 3-kinase
    Patent number: 8404684
    Abstract: Compounds of formula I in free or salt form, wherein R1, R2, R3 and R4 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
    Type: Grant
    Filed: January 12, 2011
    Date of Patent: March 26, 2013
    Assignee: Novartis AG
    Inventors: Ian Bruce, Bernard Cuenoud, Thomas Hugo Keller, Gaynor Elizabeth Pilgrim, Nicola Press, Darren Mark Le Grand, Cathy Ritchie, Barbara Valade, Judy Hayler, Emma Budd
  • beta-2-Adrenoreceptor Agonists
    Publication number: 20120302531
    Abstract: Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
    Type: Application
    Filed: July 23, 2012
    Publication date: November 29, 2012
    Inventors: Bernard Cuenoud, Ian Bruce, Robin Alec Fairhurst, David Beattie
  • Beta-2-adrenoreceptor agonists
    Patent number: 8283362
    Abstract: Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
    Type: Grant
    Filed: November 14, 2011
    Date of Patent: October 9, 2012
    Assignee: Novartis AG
    Inventors: Bernard Cuenoud, Ian Bruce, Robin A Fairhurst, David Beattie
  • Mixtures or Organic Compounds for the Treatment of Airway Diseases
    Publication number: 20120108555
    Abstract: A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.
    Type: Application
    Filed: January 9, 2012
    Publication date: May 3, 2012
    Inventors: Bernard Cuenoud, Robin Alec Fairhurst, Nicholas Lowther
  • Beta-2-Adrenoreceptor Agonists
    Publication number: 20120077838
    Abstract: Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
    Type: Application
    Filed: November 14, 2011
    Publication date: March 29, 2012
    Inventors: Bernard Cuenoud, Ian Bruce, Robin Alec Fairhurst, David Beattie
  • Beta-2-adrenoreceptor agonists
    Patent number: 8067437
    Abstract: Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
    Type: Grant
    Filed: September 20, 2010
    Date of Patent: November 29, 2011
    Assignee: Novartis AG
    Inventors: Bernard Cuenoud, Ian Bruce, Robin A Fairhurst, David Beattie
  • 5-Phenylthiazole derivatives and their use as p13 kinase inhibitors
    Patent number: 8017608
    Abstract: Compounds of formula I in free or salt form, wherein R1, R2, R3, R4 and R5 have the meanings as indicated in the specification, are useful for treating diseases mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
    Type: Grant
    Filed: March 5, 2004
    Date of Patent: September 13, 2011
    Assignee: Novartis AG
    Inventors: Graham Charles Bloomfield, Ian Bruce, Catherine Leblanc, Mrinalini Sachin Oza, Lewis Whithead, Bernard Cuenoud, Thomas Hugo Keller, Louise Kirman, Clive McCarthy, Gaynor Elizabeth Woodward
  • INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE
    Publication number: 20110105535
    Abstract: Compounds of formula I in free or salt form, wherein R1, R2, R3 and R4 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by phosphatidylinositol 3-kinase. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
    Type: Application
    Filed: January 12, 2011
    Publication date: May 5, 2011
    Inventors: Ian BRUCE, Bernard Cuenoud, Thomas Hugo Keller, Gaynor Elizabeth Pilgrim, Nicola Press, Darren Mark Le Grand, Cathy Ritchie, Barbara Valade, Judy Hayler, Emma Budd
  • Beta-2-Adrenoreceptor Agonists
    Publication number: 20110034509
    Abstract: Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
    Type: Application
    Filed: September 20, 2010
    Publication date: February 10, 2011
    Inventors: Bernard Cuenoud, Ian Bruce, Robin Alec Fairhurst, David Beattie
  • Beta-2-adrenoreceptor agonists
    Patent number: 7820694
    Abstract: Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
    Type: Grant
    Filed: October 13, 2009
    Date of Patent: October 26, 2010
    Assignee: Novartis AG
    Inventors: Bernard Cuenoud, Ian Bruce, Robin A Fairhurst, David Beattie
  • Quinoline-2-one derivatives for the treatment of airways diseases
    Patent number: 7745462
    Abstract: Compounds of formula I in free or salt form, wherein —C—Y—, R1 and R2 are G have the meanings as indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the ?2-adrenoreceptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
    Type: Grant
    Filed: April 2, 2004
    Date of Patent: June 29, 2010
    Assignee: Novartis AG
    Inventors: Robin Alec Fairhurst, David Andrew Sandham, David Beattie, Ian Bruce, Bernard Cuenoud, Reamonn Madden, Neil John Press, Roger John Taylor, Katharine Louise Turner, Simon James Watson
  • MIXTURES OR ORGANIC COMPOUNDS FOR THE TREATMENT OF AIRWAY DISEASES
    Publication number: 20100068288
    Abstract: A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.
    Type: Application
    Filed: October 9, 2009
    Publication date: March 18, 2010
    Inventors: Bernard Cuenoud, Robin Alec Fairhurst, Nicholas Lowther
  • BETA-2-ADRENORECEPTOR AGONISTS
    Publication number: 20100029705
    Abstract: Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
    Type: Application
    Filed: October 13, 2009
    Publication date: February 4, 2010
    Inventors: Bernard Cuenoud, Ian BRUCE, Robin Alec FAIRHURST, David BEATTIE
  • Mixtures or organic compounds for the treatment of airway diseases
    Patent number: 7622484
    Abstract: A medicament comprising, separately or together, (A) a compound of formula (I) in free or pharmaceutically acceptable salt or solvate form and (B) a corticosteroid, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease, the molar ratio of (A) to (B) being from 100:1 to 1:300.
    Type: Grant
    Filed: October 12, 2005
    Date of Patent: November 24, 2009
    Assignee: Novartis AG
    Inventors: Bernard Cuenoud, Robin A Fairhurst, Nicholas Lowther
  • ?2-adrenoceptor agonists
    Patent number: 7622483
    Abstract: Compounds of formula in free or salt or solvate form, where Ar is a group of formula Y is carbon or nitrogen and R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, X, n, p, q and r are as defined in the specification, their preparation and their use as pharmaceuticals, particularly for the treatment of obstructive or inflammatory airways diseases.
    Type: Grant
    Filed: March 7, 2005
    Date of Patent: November 24, 2009
    Assignee: Novartis AG
    Inventors: Bernard Cuenoud, Ian Bruce, Robin A Fairhurst, David Beattie